IQV: Flat Base detected on 25 Sep 2026

IQV is forming a flat base pattern with a weak accompanying bullish engulfing from September 23rd. The structure score of 7.0 indicates the base is developing but not yet mature. Price rests at $275.02, near resistance at $277.40 with key support at $227.15 (43.5% below current). Volume ratio of 1.16x shows modest above-average activity. The breakout score of 9.0 and overall score of 60.0 suggest a lower-quality setup—consolidation is forming but lacks the conviction typically seen in stronger bases. RSI at 67.07 indicates nearness to overbought but not excessive.

IQVIA reported Q2 2026 adjusted earnings of $3.15 per share, rising 12.1% year-over-year and beating estimates of $3.02 by 4.3%. Revenues of $4.36 billion increased 8.7% and topped consensus of $4.29 billion by 1.6%. R&D Solutions generated record net new bookings of $3.15 billion, up 19% year-over-year, producing a 1.22x book-to-bill ratio. Organic revenue growth accelerated to 6% year-over-year, tripling the rate from the prior year. The R&D Solutions segment benefited from improved demand and the company expects AI to contribute more directly to top-line growth as clients move from pilot programs to broad deployment of IQVIA AI agents. Wall Street consensus shows 14 buy, 7 hold, 0 sell. This earnings momentum in a bullish healthcare sector (regime score 0.62) is driving the 47.52% three-month gain and supporting the consolidation structure.

A breakout above resistance at $277.40 would target the conservative measured move to $286.66, representing approximately 4.2% upside from current price. Volume confirmation is needed above the 1.64 million average to validate the breakout—current volume of 1.89 million shows capacity. The invalidation level sits at $227.15 support; a close below this would negate the setup. With win probability at 53.51%, the pattern suggests slight edge—marginally better than a coin flip. The low structure score (7.0) means this is a lower-conviction base; breakout validation will be critical.

Analyst median price target for IQV is $223.0, well below current price of $275.02, suggesting significant downside risk if sentiment shifts. The stock sits 78% above its 52-week low and only 0.86% below the 52-week high, positioning at an extended level with limited cushion to previous peaks. RSI at 67.07 is elevated, approaching overbought—pullback risk is present. MACD histogram at -0.5621 is negative, diverging from price strength and signaling potential momentum weakness. Beta of 0.61 offers some downside protection, but the pattern quality score of 24.0 overall is weak; the structure and breakout scores are both modest (7.0 and 9.0 respectively). The next earnings date and any guidance revision could trigger sharp moves. Market regime is neutral (-0.17), offering no tailwind support if momentum stalls.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.